These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19373442)

  • 1. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
    Forones NM; de Lima JM; de Souza LG; da Silva ID
    J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
    Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
    Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
    Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
    Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated risk of colorectal cancer associated with the AA genotype of the cyclin D1 A870G polymorphism in an Indian population.
    Jiang J; Wang J; Suzuki S; Gajalakshmi V; Kuriki K; Zhao Y; Nakamura S; Akasaka S; Ishikawa H; Tokudome S
    J Cancer Res Clin Oncol; 2006 Mar; 132(3):193-9. PubMed ID: 16328437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
    Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
    Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
    McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
    Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
    Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
    Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of cyclin D1 genotype with breast cancer risk and survival.
    Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
    Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
    Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
    Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
    Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
    Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
    Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
    Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
    Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin D1 G870A polymorphism and risk of colorectal cancer: a case control study.
    Sameer AS; Parray FQ; Dar MA; Nissar S; Banday MZ; Rasool S; Gulzar GM; Chowdri NA; Siddiqi MA
    Mol Med Rep; 2013 Mar; 7(3):811-5. PubMed ID: 23354584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
    Wang L; Habuchi T; Takahashi T; Mitsumori K; Kamoto T; Kakehi Y; Kakinuma H; Sato K; Nakamura A; Ogawa O; Kato T
    Carcinogenesis; 2002 Feb; 23(2):257-64. PubMed ID: 11872630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
    Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
    Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single Nucleotide Polymorphism (A870G) of the
    Montazer Haghighi M; Vahedi M; Nazemolhosseini Mojarad E
    Gastroenterol Hepatol Bed Bench; 2017; 10(Suppl1):S48-S53. PubMed ID: 29511472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
    Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
    J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab.
    Zhang W; Gordon M; Press OA; Rhodes K; Vallböhmer D; Yang DY; Park D; Fazzone W; Schultheis A; Sherrod AE; Iqbal S; Groshen S; Lenz HJ
    Pharmacogenet Genomics; 2006 Jul; 16(7):475-83. PubMed ID: 16788380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
    Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
    Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.